SEPN earnings date and last-quarter result: next report 2026-08-10, last quarter miss, P/E -42.22. Updated 2026-07-23.
Septerna (SEPN) Research Hub
Septerna (SEPN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 41.38 USD (+2.40%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -42.22, market cap 1.50B. This hub links to the full technical, earnings and options research available for SEPN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 41.38 USD (+2.40%) |
| 52-week range | 31.44 USD – 48.95 USD |
| Trend regime | Range |
| 14-day RSI | 72 (Overbought) |
| Trailing P/E | -42.22 |
| Market cap | 1.50B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for SEPN
Covered Call on SEPN: how it works, illustrative setup around the real 41.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SEPN: how it works, illustrative setup around the real 41.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SEPN: how it works, illustrative setup around the real 41.38 USD price, max profit/loss, breakeven and when to use it. Educational.
SEPN technical analysis: range, last 41.38 USD, RSI 72, 52w range 31.44 USD–48.95 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SEPN in?
Septerna (SEPN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SEPN in an uptrend or downtrend?
As of 2026-10-26, SEPN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SEPN's trailing P/E ratio?
SEPN's trailing P/E is -42.22, with a market cap of 1.50B. See the earnings research page for full valuation detail.
When does SEPN next report earnings?
SEPN is next scheduled to report earnings on 2026-08-10.